Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

著者: Daniel Khalaf, Matti Annala, Sinja Taavitsainen, Daygen L. Finch, Conrad D. Oja, Joanna Vergidis, Muhammad Zulfiqar, Katherine Sunderland, Arun Azad, Christian Kollmannsberger, Bernhard J. Eigl, Krista Noonan, Deepa Wadhwa, Andrew Attwell, Bruce Keith, Susan Ellard, Lyly Le, Martin Gleave, Alexander W. Wyatt, Kim N. - The Lancet 2019 被引用: 352